The OTC Monograph Public Meeting begins today at the Food and Drug Administration's White Oak campus in Silver Springs, MD.
FDA is asking input on how to improve the current OTC Monograph Process for reviewing certain nonprescription drugs. This public hearing is being held to obtain information and comments from the public on the strengths and weaknesses of the current OTC Monograph Process, the feasibility of potential modifications the Agency has identified, and ideas about other modifications or alternatives to this process.
Today’s lineup includes: Janet Woodcock, MD (Director, Center for Drug Evaluation and Research), Greg Collier (Procter & Gamble Company), Elizabeth Anderson (Personal Care Products Council) and Craig Weiss (Independent Cosmetic Manufacturing and Distribution, ICMAD.)
The hearing continues tomorrow, and on the docket is David Steinberg of Steinberg and Associates.